| cross-sectional survey of the extent and indicators of hepatitis c virus infection in houston department of health and human services' sexually transmitted disease clinics. | to evaluate the prevalence and indicators of hepatitis c virus (hcv) infection in houston and determine the effectiveness of targeted hcv screening in sexually transmitted disease (std) clinics. we performed a cross-sectional survey in low-risk and high-risk groups in houston. this included a blinded survey of hcv conducted in 1010 std clinic clients having serological syphilis tests, and 1885 multi-speciality group practice patients having metabolic blood work. this was followed with a targeted ... | 2003 | 12614470 |
| randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis c genotype 6. | hepatitis c virus (hcv) genotype is an important criteria in determining duration of therapy and predictor of sustained virologic response (svr) to pegylated interferon (peg ifn) and ribavirin (rbv) therapy. optimal duration of therapy for patients with hcv genotype 6 is not known. we conducted a multicenter, open-label randomized controlled trial of patients with hcv genotype 6 at five gastroenterology clinics in the western u.s. patients were stratified by viral load and histologic stage and a ... | 2010 | 21038410 |
| end-stage liver disease in a state prison population. | information on the epidemiology of end-stage liver disease (esld) in us correctional populations is limited. we examined the prevalence, mortality and clinical characteristics of esld in the nation's second largest state prison system. | 2007 | 17689260 |